Entry Detail



General Information

Database ID:exR0429415
RNA Name:APP
RNA Type:mRNA
Chromosome:chr21
Starnd:-
Coordinate:
Start Site(bp):25880550End Site(bp):26171128
External Links:ENSG00000142192



Disease Information

Disease Name:Pediatric TB meningitis
Disease Category:Infections
MeSH ID:D014390
Type:Diseases Category/Infections
Alias:Tuberculosis, Meningeal//Meningeal Tuberculoses//Meningeal Tuberculosis//Tuberculoses, Meningeal//TB Meningitis//TB Meningitides//Tubercular Meningitis//Meningitides, Tubercular//Meningitis, Tubercular//Tubercular Meningitides//Meningitis, Tuberculous//Meningitides, Tuberculous//Tuberculous Meningitides//Tuberculous Meningitis//Tuberculosis Meningitis//Meningitides, Tuberculosis//Meningitis, Tuberculosis//Tuberculosis Meningitides//Tuberculous Hypertrophic Pachymeningitis//Hypertrophic Pachymeningitides, Tuberculous//Hypertrophic Pachymeningitis, Tuberculous//Pachymeningitides, Tuberculous Hypertrophic//Pachymeningitis, Tuberculous Hypertrophic//Tuberculous Hypertrophic Pachymeningitides



Expression Detail

GEO ID:GSE122377
Description:Tuberculous Meningitis in Pediatric Patients [CSF]
Experimental Design:Disease Sample Source
Case Disease Type:Pediatric TB meningitis
Case Disease SubType:NA
Case Sample:Pediatric TB meningitis
Control Sample:Lumbar Puncture Cerebrospinal Fluid
Number of Case:12
Number of Control:12
Number of Samples:24





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABCF2
chr7
151207837
151227166
-
ABRACL
chr6
139028745
139043302
+
AC008695.1
chr5
131425891
131796983
-
AC012254.2
chr18
47108188
47176345
-
AC093525.2
chr16
2496032
2520218
+
AC138811.2
chr16
18788063
18801519
-
AC245033.1
chr15
82536788
82573194
-
ACAA2
chr18
49782164
49813953
-
ACTB
chr7
5527148
5563784
-
ACTG1
chr17
81509971
81523847
-
ACTR10
chr14
58200080
58235636
+
ADAR
chr1
154582057
154628013
-
ADI1
chr2
3497366
3519531
-
ADK
chr10
74151202
74709963
+
AGL
chr1
99850361
99924023
+
AGPAT1
chr6
32168212
32178096
-
AHNAK
chr11
62433542
62556235
-
AIF1L
chr9
131096476
131123152
+
AKIRIN1
chr1
38991276
39006059
+
AL133352.1
chr10
100505628
100529881
-
AL136454.1
chr1
192716132
192716653
+
AL139011.2
chr1
160216800
160285130
-
AL355916.3
chr14
61529128
61657964
+
AL589666.1
chr6
85557978
85615234
-
ALAS1
chr3
52198086
52214327
+
ALDOA
chr16
30064164
30070457
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-17-5p
chr13
91350618
91350640
+
hsa-miR-20a-5p
chr13
91351072
91351094
+
hsa-miR-21-5p
chr17
59841273
59841294
+
hsa-miR-29a-3p
chr7
130876748
130876769
-
hsa-miR-29b-3p
chr7
130877467
130877489
-
hsa-miR-106a-5p
chrX
134170244
134170266
-
hsa-miR-214-3p
chr1
172138816
172138837
-
hsa-miR-106b-5p
chr7
100094043
100094063
-
hsa-miR-29c-3p
chr1
207801865
207801886
-
hsa-miR-302a-3p
chr4
112648186
112648208
-
hsa-miR-302c-3p
chr4
112648366
112648388
-
hsa-miR-373-3p
chr19
53788748
53788770
+
hsa-miR-20b-5p
chrX
134169850
134169872
-
hsa-miR-520e-3p
chr19
53675764
53675784
+
hsa-miR-520a-3p
chr19
53690933
53690954
+
hsa-miR-520b-3p
chr19
53701267
53701287
+
hsa-miR-520c-3p
chr19
53707506
53707527
+
hsa-miR-520d-3p
chr19
53720149
53720170
+
hsa-miR-4426
chr1
192716333
192716349
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC016876.2
chr17
7581964
7584086
-
AC021078.1
chr5
149494314
149504670
-
AC023509.1
chr12
53441741
53467528
+
AC024940.6
chr12
31280422
31280895
-
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:31434901
Title:Tuberculous meningitis in children is characterized by compartmentalized immune responses and neural excitotoxicity
Author:Rohlwink UK, Figaji A, Wilkinson KA, Horswell S, Sesay AK, Deffur A, Enslin N, Solomons R, Van Toorn R, Eley B, Levin M, Wilkinson RJ, Lai RPJ
Journal:Nat Commun. 2019 Aug 21;10(1):3767.
Description:Differential transcript expression of TBM cases are compared with healthy controls in whole blood and with non-TB cerebral infection controls in CSF.